C4 Therapeutics, Inc. (CCCC) has been on a downward spiral lately with significant selling pressure. After declining 26.2% over the past four weeks, the stock looks well positioned for a trend ...

C4 Therapeutics, Inc. (CCCC) has been beaten down lately with too much selling pressure. While the stock has lost 21.9% over the past four weeks, there is light at the end of the tunnel as it is ...